Skip to main content
Clinical Trials/SLCTR/2024/026
SLCTR/2024/026
Not Yet Recruiting
N/A

Study of agreement between Paxxy fetal heart rate and maternal heart rate monitoring with CTG and pulse oximetry.

Paxxy FMS LLC0 sites30 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Paxxy FMS LLC
Enrollment
30
Status
Not Yet Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Paxxy FMS LLC

Eligibility Criteria

Inclusion Criteria

  • All term mothers (37\+0 \- 41\+7\) presenting to the professorial unit of De Soysa Hospital for Women.
  • Have clinical indications for fetal monitoring.
  • Age 18\-45 years.

Exclusion Criteria

  • 1\. Multiple pregnancy
  • 2\. Fetal growth restriction
  • 3\. Hypertension and diabetes in pregnancy
  • 4\. BMI\>30
  • 5\. Significant uterine anomalies such as didelphys or bicornuate uterus (Women with small ,clinically insignificant anomalies such as uterine fibroids are not excluded)
  • 6\. Inability to fit both Paxxy and CTG due to fetal position.
  • 7\. Known allergy to ECG pad adhesive.

Outcomes

Primary Outcomes

Not specified

Similar Trials